SCHEMBL4895733

SCHEMBL4895733

CCc1ccc(S(=O)(=O)N(CC)c2ccc(Oc3ccc(Cl)cc3)cc2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
PGR P06401 3/20 0.50
NR3C1 P04150 1/20 0.50
MCL1 Q07820 8/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BCL2L1 Q07817 5/20 0.46
CNR2 P34972 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906440 0.91 LMNA (0.61) LMNAPGRNR3C1MCL1ALDH1A1
SCHEMBL4905653 0.90 LMNA (0.58) LMNAMEN1KMT2APGRMCL1
SCHEMBL4902984 0.89 ALDH1A1 (0.50) LMNAMEN1KMT2APGRNR3C1
SCHEMBL4898076 0.89 LMNA (0.58) LMNAKMT2ANR3C1MCL1ALDH1A1
SCHEMBL4906805 0.89 LMNA (0.56) LMNAMEN1KMT2APGRNR3C1
SCHEMBL4904663 0.88 LMNA (0.52) LMNAMCL1ALDH1A1HPGDALOX15
SCHEMBL4900991 0.87 LMNA (0.51) LMNAMCL1ALDH1A1HPGDALOX15
SCHEMBL4895112 0.87 LMNA (0.59) LMNAMCL1ALDH1A1HPGDALOX15
SCHEMBL4903163 0.86 LMNA (0.53) LMNAMEN1KMT2AMCL1ALDH1A1
SCHEMBL4899886 0.86 LMNA (0.53) LMNANR3C1MCL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885MEN1 4855/4885KMT2A 3530/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885MEN1 4855/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.